Jennifer Jarrett, insider filing for GLTO
Jennifer Jarrett, reporting
DMRA
Damora Therapeutics, Inc. SEC filings
Every EDGAR filing for Damora Therapeutics, Inc. (DMRA), newest first, with AI summaries and stories.
- Ticker
- DMRA
- CIK
- 1800315
- Latest filing
- Sep 28
Next: earnings expected ~Nov 9 ยท 10-Q expected ~Nov 9 (deadline Nov 16)
Insider activity
- Officer bought $253K
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE4Damora Therapeutics, Inc.GLTOLIVE ROUTINE4Damora Therapeutics, Inc.GLTOLIVE 2 insider filings
Andrew Cheng, insider filing for GLTO
Show all 2
- 4Insider filing for GLTO
- 3New insider at GLTO
Andrew Cheng, reporting
ROUTINEEFFECTDamora Therapeutics, Inc.GLTOLIVE ROUTINES-8 POSDamora Therapeutics, Inc.GLTOLIVE ROUTINES-8 POSDamora Therapeutics, Inc.GLTOLIVE ROUTINEPOSASRDamora Therapeutics, Inc.GLTOLIVE ROUTINES-8 POSDamora Therapeutics, Inc.GLTOLIVE ROUTINES-8 POSDamora Therapeutics, Inc.GLTOLIVE ROUTINES-8 POSDamora Therapeutics, Inc.GLTOLIVE ROUTINES-8 POSDamora Therapeutics, Inc.GLTOLIVE ROUTINES-8 POSDamora Therapeutics, Inc.GLTOLIVE ROUTINES-8 POSDamora Therapeutics, Inc.GLTOLIVE ROUTINEPOS AMDamora Therapeutics, Inc.GLTOLIVE ROUTINE8-A12B/ADamora Therapeutics, Inc.GLTOLIVE NOTABLE10-QDamora Therapeutics, Inc.GLTOLIVE ROUTINE144Damora Therapeutics, Inc.GLTOLIVE Lori Firmani, planned sale of GLTO shares
Lori Firmani, reporting
ROUTINESCHEDULE 13GDamora Therapeutics, Inc.GLTOLIVE Ownership stake disclosure by BlackRock, Inc.
BlackRock, Inc., filed by
ROUTINE8-KDamora Therapeutics, Inc.GLTOLIVE ROUTINE4Damora Therapeutics, Inc.GLTOLIVE Garrett Winslow, insider filing for GLTO
Garrett Winslow, reporting
ROUTINE144Damora Therapeutics, Inc.GLTOLIVE Lori Firmani, planned sale of GLTO shares
Lori Firmani, reporting
ROUTINE8-KDamora Therapeutics, Inc.GLTOLIVE ROUTINESCHEDULE 13G/ADamora Therapeutics, Inc.GLTOLIVE 2 13G filings
Ownership stake disclosure by Point72 Asset Management, L.P. (amended)
Show all 2
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13G/AOwnership stake disclosure (amended)
Point72 Asset Management, L.P., filed by
ROUTINESCHEDULE 13GDamora Therapeutics, Inc.GLTOLIVE Ownership stake disclosure by Avoro Capital Advisors LLC
Avoro Capital Advisors LLC, filed by
NOTABLE10-QDamora Therapeutics, Inc.GLTOLIVE ROUTINE3Damora Therapeutics, Inc.GLTOLIVE Brian Burkavage, new insider at GLTO
Brian Burkavage, reporting
ROUTINE8-KDamora Therapeutics, Inc.GLTOLIVE ROUTINEARSDamora Therapeutics, Inc.GLTOLIVE ROUTINEDEF 14ADamora Therapeutics, Inc.GLTOLIVE ROUTINEDEFA14ADamora Therapeutics, Inc.GLTOLIVE ROUTINESCHEDULE 13G/ADamora Therapeutics, Inc.GLTOLIVE 2 13G filings
Ownership stake disclosure by Paramora Holding LLC (amended)
Show all 2
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13G/AOwnership stake disclosure (amended)
Paramora Holding LLC, filed by
ROUTINE8-KDamora Therapeutics, Inc.GLTOLIVE ROUTINE4Damora Therapeutics, Inc.GLTOLIVE 2 insider filings
Jennifer Jarrett, insider filing for GLTO
Show all 2
- 4Insider filing for GLTO
- 3New insider at GLTO
Jennifer Jarrett, reporting
ROUTINE4Damora Therapeutics, Inc.GLTOLIVE 8 insider filings
Garrett Winslow, insider filing for GLTO
Show all 8
- 4Insider filing for GLTO
- 4Insider filing for GLTO
- 4Insider filing for GLTO
- 4Insider filing for GLTO
- 4Insider filing for GLTO
- 4Insider filing for GLTO
- 3New insider at GLTO
- 3New insider at GLTO
Garrett Winslow, reporting
ROUTINE8-KDamora Therapeutics, Inc.GLTOLIVE ROUTINES-8Damora Therapeutics, Inc.GLTOLIVE NOTABLE10-KDamora Therapeutics, Inc.GLTOLIVE ROUTINE8-KGalecto, Inc.GLTOLIVE ROUTINESCHEDULE 13G/AGalecto, Inc.GLTOLIVE Ownership stake disclosure by Ikarian Capital, LLC (amended)
Ikarian Capital, LLC, filed by
ROUTINESCHEDULE 13GGalecto, Inc.GLTOLIVE Ownership stake disclosure by Venrock Healthcare Capital Partners III, L.P.
Venrock Healthcare Capital Partners III, L.P., filed by